145 related articles for article (PubMed ID: 36119648)
1. Postcovid Syndrome - The New Reality.
Khoreva MA
Neurosci Behav Physiol; 2022; 52(5):619-624. PubMed ID: 36119648
[TBL] [Abstract][Full Text] [Related]
2. [Postcovid syndrome - a new reality].
Khoreva MA
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10):131-137. PubMed ID: 34874668
[TBL] [Abstract][Full Text] [Related]
3. [Sleep Disorders in Patients After COVID-19].
Ahmet'yanov MA; Reikhert LI; Kicherova OA; Deeva MV; Makarova DV
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(12):119-122. PubMed ID: 35041323
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychological disorders after COVID-19. Urgent need for research and clinical practice.
Łojek E; Egbert AR; Gambin M; Gawron N; Gorgol J; Hansen K; Holas P; Hyniewska S; Malinowska E; Pluta A; Sękowski M; Vitvitska O; Wyszomirska J; Żarnecka D
Postep Psychiatr Neurol; 2021 Jun; 30(2):104-112. PubMed ID: 37082436
[TBL] [Abstract][Full Text] [Related]
5. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.
Borah P; Deb PK; Chandrasekaran B; Goyal M; Bansal M; Hussain S; Shinu P; Venugopala KN; Al-Shar'i NA; Deka S; Singh V
Front Mol Biosci; 2021; 8():627723. PubMed ID: 33681293
[TBL] [Abstract][Full Text] [Related]
6. Rehabilitation Strategies for Cognitive and Neuropsychiatric Manifestations of COVID-19.
Rolin S; Chakales A; Verduzco-Gutierrez M
Curr Phys Med Rehabil Rep; 2022; 10(3):182-187. PubMed ID: 35602927
[TBL] [Abstract][Full Text] [Related]
7. A Reminder of Skin Cancer During the COVID-19 Pandemic.
Šitum M; Filipović N; Buljan M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
[TBL] [Abstract][Full Text] [Related]
8. [Determination of the prevalence of postcovid syndrome and assessment of the effectiveness of the drug Cortexin in the treatment of neurological disorders in patients with postcovid syndrome. Results of the multicenter clinical and epidemiological observational program CORTEX].
Putilina MV; Mutovina ZY; Kurushina OV; Khalilova DM; Saverskaya EN; Stepanova SB; Khoreva MA; Starikov AS
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(1):84-90. PubMed ID: 35175707
[TBL] [Abstract][Full Text] [Related]
9. Sleep Disorders in Patients after COVID-19.
Ahmet'yanov MA; Reikhert LI; Kicherova OA; Veeva DM; Makarova DV
Neurosci Behav Physiol; 2022; 52(5):645-648. PubMed ID: 36119651
[TBL] [Abstract][Full Text] [Related]
10. Neurological manifestations of long-COVID syndrome: a narrative review.
Stefanou MI; Palaiodimou L; Bakola E; Smyrnis N; Papadopoulou M; Paraskevas GP; Rizos E; Boutati E; Grigoriadis N; Krogias C; Giannopoulos S; Tsiodras S; Gaga M; Tsivgoulis G
Ther Adv Chronic Dis; 2022; 13():20406223221076890. PubMed ID: 35198136
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 atypical Parsonage-Turner syndrome: a case report.
Zazzara MB; Modoni A; Bizzarro A; Lauria A; Ciciarello F; Pais C; Galluzzo V; Landi F; Tostato M;
BMC Neurol; 2022 Mar; 22(1):96. PubMed ID: 35296278
[TBL] [Abstract][Full Text] [Related]
12. Neuro-COVID-19: an insidious virus in action.
Bratosiewicz-Wąsik J
Neurol Neurochir Pol; 2022; 56(1):48-60. PubMed ID: 34642927
[TBL] [Abstract][Full Text] [Related]
13. [COVID-19 and the central and peripheral nervous system].
Ritschel N; Radbruch H; Herden C; Schneider N; Dittmayer C; Franz J; Thomas C; Silva Boos G; Pagenstecher A; Schulz-Schaeffer W; Stadelmann C; Glatzel M; Heppner FL; Weis J; Sohrabi K; Schänzer A; Németh A; Acker T; ;
Pathologe; 2021 Mar; 42(2):172-182. PubMed ID: 33646363
[TBL] [Abstract][Full Text] [Related]
14. [Neurological disorders in the postcovid period].
Fedin AI
Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(10):31-37. PubMed ID: 36279226
[TBL] [Abstract][Full Text] [Related]
15. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
[TBL] [Abstract][Full Text] [Related]
16. K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research.
Dedoni S; Avdoshina V; Camoglio C; Siddi C; Fratta W; Scherma M; Fadda P
Molecules; 2022 Jun; 27(13):. PubMed ID: 35807384
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychological functioning in severe acute respiratory disorders caused by the coronavirus: Implications for the current COVID-19 pandemic.
Rabinovitz B; Jaywant A; Fridman CB
Clin Neuropsychol; 2020; 34(7-8):1453-1479. PubMed ID: 32901580
[No Abstract] [Full Text] [Related]
18. The Other Side of SARS-CoV-2 Infection: Neurological Sequelae in Patients.
Alonso-Bellido IM; Bachiller S; Vázquez G; Cruz-Hernández L; Martínez E; Ruiz-Mateos E; Deierborg T; Venero JL; Real LM; Ruiz R
Front Aging Neurosci; 2021; 13():632673. PubMed ID: 33889082
[TBL] [Abstract][Full Text] [Related]
19. Determination of the Prevalence of Postcovid Syndrome and Assessment of the Effectiveness of the Drug Cortexin in the Treatment of Neurological Disorders in Patients with Postcovid Syndrome. Results of the CORTEX Multicenter Clinical and Epidemiological Observational Program.
Putilina MV; Mutovina ZY; Kurushina OV; Khalilova DM; Saverskaya EN; Stepanova SB; Khoreva MA; Starikov AS
Neurosci Behav Physiol; 2022; 52(6):836-841. PubMed ID: 36311877
[No Abstract] [Full Text] [Related]
20. Inflammation at the crossroads of COVID-19, cognitive deficits and depression.
Lyra E Silva NM; Barros-Aragão FGQ; De Felice FG; Ferreira ST
Neuropharmacology; 2022 May; 209():109023. PubMed ID: 35257690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
